Doctor profile · Federal record
Dr. Sudarsan Kollimuttathuillam, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Irvine, CA
- NPI 1902324528
- Accepts Medicare
- MIPS 91.9 / 100 · 2023
- 14 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
16300 Sand Canyon Ave Ste 207
Irvine, CA 926183712
(949) 333-7580
fax (949) 333-7599 - Additional location
-
1000 Fivepoint
Irvine, CA 926182377
(949) 671-4673
fax (949) 671-4329 - Additional location
-
2100 Main St Ste 300
Huntington Beach, CA 926482489
(714) 252-9415
fax (714) 963-8407 - Mailing address
-
Po Box 512185
Los Angeles, CA 900510185
Credentials & registration
- NPI registered
- September 2017 — 9 yrs on file
- Profile last updated
- May 30, 2024
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #A169385
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1902324528. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
67,099
Distinct HCPCS
10
Medicare allowed
$1,379,825
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 21,000 | 22 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 10,400 | 15 | $55 | |
J3380 |
Injection, vedolizumab, 1 mg | 8,700 | 13 | $22 | |
J0185 |
Injection, aprepitant, 1 mg | 6,890 | 20 | $2 | |
J0897 |
Injection, denosumab, 1 mg | 5,040 | 51 | $23 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 3,780 | 12 | $10 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 2,875 | 14 | $42 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 1,784 | 16 | $44 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 1,430 | 14 | $33 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 1,240 | 32 | $0 |
In context: peer comparison
Among 5 peers in Irvine Hematology & Oncology Physician, average services per provider: 1,303. This provider delivers 51× the peer median.Open Payments
Industry payments received
All-time total
$1,234
Transactions
27
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 4 | $426.53 | |
| Celgene Corporation | 12 | $235.02 | |
| Astellas Pharma US INC | 2 | $141.46 | |
| Menarini Silicon Biosystems, INC. | 1 | $102.44 | |
| Takeda Pharmaceuticals U.S.A., INC. | 2 | $86.21 | |
| Daiichi Sankyo INC. | 2 | $83.45 | |
| Genzyme Corporation | 1 | $78.67 | |
| Merck Sharp & Dohme LLC | 2 | $46.34 | |
| Exelixis INC. | 1 | $33.56 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
192
Patients
0
Total drug cost
$1,457,592
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Pantoprazole Sodium | Generic | 33 | 0 | $299 |
| Eliquis (Apixaban) | Brand | 30 | 0 | $26,050 |
| Cabometyx (Cabozantinib S-Malate) | Brand | 22 | 0 | $622,524 |
| Erleada (Apalutamide) | Brand | 18 | 0 | $288,024 |
| Folic Acid | Generic | 15 | 0 | $52 |
| Anastrozole | Generic | 14 | 0 | $272 |
| Levothyroxine Sodium | Generic | 14 | 0 | $210 |
| Revlimid (Lenalidomide) | Brand | 13 | 0 | $128,753 |
| Alecensa (Alectinib Hcl) | Brand | 11 | 0 | $205,852 |
| Hydroxyurea | Generic | 11 | 0 | $477 |
Hospital affiliations
Frequently asked questions
What is Dr. Sudarsan Kollimuttathuillam's medical specialty?
Dr. Sudarsan Kollimuttathuillam practices Hematology & Oncology Physician in Irvine, CA.
Where does Dr. Sudarsan Kollimuttathuillam practice?
Dr. Sudarsan Kollimuttathuillam practices at 16300 Sand Canyon Ave Ste 207, Irvine, CA 926183712. Office phone: 9493337580.
What is Dr. Sudarsan Kollimuttathuillam's NPI?
Dr. Sudarsan Kollimuttathuillam's National Provider Identifier (NPI) is 1902324528, issued by NPPES.
Does Dr. Sudarsan Kollimuttathuillam accept Medicare assignment?
Yes. Dr. Sudarsan Kollimuttathuillam accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sudarsan Kollimuttathuillam commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, vedolizumab, 1 mg (HCPCS J3380). Source: CMS Medicare Physician & Other Practitioners file.